Endoglin Is an Important Mediator in the Final Common Pathway of Chronic Kidney Disease to End-Stage Renal Disease.

MLA

Gerrits, Tessa, et al. “Endoglin Is an Important Mediator in the Final Common Pathway of Chronic Kidney Disease to End-Stage Renal Disease.” International Journal of Molecular Sciences, vol. 24, no. 1, Dec. 2022. EBSCOhost, https://doi.org/10.3390/ijms24010646.

APA

Gerrits, T., Brouwer, I. J., Dijkstra, K. L., Wolterbeek, R., Bruijn, J. A., Scharpfenecker, M., & Baelde, H. J. (2022). Endoglin Is an Important Mediator in the Final Common Pathway of Chronic Kidney Disease to End-Stage Renal Disease. International Journal of Molecular Sciences, 24(1). https://doi.org/10.3390/ijms24010646

Chicago

Gerrits, Tessa, Isabella J Brouwer, Kyra L Dijkstra, Ron Wolterbeek, Jan A Bruijn, Marion Scharpfenecker, and Hans J Baelde. 2022. “Endoglin Is an Important Mediator in the Final Common Pathway of Chronic Kidney Disease to End-Stage Renal Disease.” International Journal of Molecular Sciences 24 (1). doi:10.3390/ijms24010646.